A reliable and applicable record states the opposite.
NMC Health said in December 2019 that the Muddy Waters report was false and misleading.
false and misleading
- About
- NMC Health plc
- Claim made by
- Gulf News, press report
- Published
- 20 December 2019
- Evidence score
- 86 How it was scored
- Last reviewed
- 25 October 2026
Why this label
Gulf News reported that NMC called the report false and misleading and listed what it said were factual errorsS3. NMC said supplier financing was booked as trade payables and that its lease treatment met the rules of the timeS3. The FCA later found that NMC's financial statements and clarification announcements published between March 2019 and February 2020 contained materially inaccurate information about debtS1. The rebuttal on debt was given inside that period. A competent regulator record states the opposite of NMC's position on its debt, so the label is Contradicted. The FCA record read here does not address every point in the short report.
Current procedural position
FCA public censure issued 17 November 2023, finalS1.
Record supporting the assessment
contained materially inaccurate information about its debt position
Between March 2019 and February 2020
Conflicting or limiting record
accounted as 'trade payables' in the balance sheet
Evidence score: 86 of 100
The score grades how well the record establishes this assessment. It is not a score of NMC Health plc. Score = source authority + directness + corroboration + procedural accuracy + currency + reproducibility.
| Component | Points | Max | Reason |
|---|---|---|---|
| Source authorityIs the source competent to establish the proposition? | 29 | 30 | A UK regulator finding on the company's own announcements. |
| DirectnessDoes the source state the proposition or only discuss adjacent facts? | 16 | 20 | The censure covers clarification announcements in the period, though it does not quote the December 2019 rebuttal. |
| CorroborationDo independent records support the same material point? | 9 | 15 | CNBC and Gulf News agree on what NMC said, the FCA is the only finding. |
| Procedural accuracyDoes the record settle the procedural state the claim describes? | 14 | 15 | The censure is final. |
| CurrencyHas the record been checked against later developments? | 9 | 10 | Checked to October 2026. |
| ReproducibilityCan a reader locate the passage and repeat the assessment? | 9 | 10 | Both the press account and the FCA release are public. |
| Total | 86 | 100 |
Timeline
Related cases
- Financial Conduct Authority v. NMC Health plc (in administration)Financial Conduct Authority (United Kingdom). Regulatory. Not published.Stage: Public censure issued
- Censure for market abuse, no financial penalty to protect creditorsS1.
Responses
- NMC Health plc, 20 December 2019: NMC called the short report false and misleading and said supplier finance was booked as trade payables.S3
Revision history
- Assessment first published with label Contradicted.
Have a record that changes this assessment? See corrections and responses.
Sources
- S1Tier A FCA censures NMC Health Plc (in Administration) for market abuseFinancial Conduct Authority. Regulator press release. 17 November 2023.Finds debt understated by as much as USD 4 billion in statements from March 2019 to February 2020. It does not address asset values or the short report point by point.Link working, checked 25 October 2026
- S3Tier C NMC refutes Muddy Waters report in detailGulf News. Press report. 20 December 2019.Reports NMC's rebuttal. It is the company's position as reported, not a finding.Link working, checked 25 October 2026
Other claims about NMC Health plc
- Supported88Muddy Waters alleged in December 2019 that NMC Health was understating its debt.Press report, 2 January 20203 records citedAccounting
- Unverifiable35Muddy Waters questioned NMC's reported investment in a hospital, saying the cost of US$7,700 per square metre was well above expected levels.Press report, 2 January 20202 records citedAccounting
- Outdated76A May 2025 report said NMC Health's administrators were suing EY for around GBP 2 billion in a trial at the High Court in London.Press report, 22 May 20253 records citedCorporate status